Healthcare Realty Trust Incorporated
HR
$16.72
$0.100.60%
| Weiss Ratings | HR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C- | |||
| Rating Factors | HR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Excellent | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.96 | |||
| Price History | HR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.00% | |||
| 30-Day Total Return | 3.39% | |||
| 60-Day Total Return | -7.00% | |||
| 90-Day Total Return | -6.71% | |||
| Year to Date Total Return | 3.39% | |||
| 1-Year Total Return | 28.43% | |||
| 2-Year Total Return | -0.65% | |||
| 3-Year Total Return | -26.21% | |||
| 5-Year Total Return | -42.37% | |||
| 52-Week High % Change | -11.53% | |||
| 52-Week Low % Change | 30.93% | |||
| Price | HR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $18.90 | |||
| 52-Week Low Price | $12.77 | |||
| 52-Week Low Price (Date) | Mar 15, 2024 | |||
| 52-Week High Price (Date) | Sep 16, 2024 | |||
| Valuation | HR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 5.87B | |||
| Enterprise Value | 10.83B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.79 | |||
| Earnings Per Share Growth | 141.07% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 4.64 | |||
| Price/Book (Q) | 1.12 | |||
| Enterprise Value/Revenue (TTM) | 8.54 | |||
| Price | $16.72 | |||
| Enterprise Value/EBITDA (TTM) | 14.33 | |||
| Enterprise Value/EBIT | 324.86 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | HR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 351.56M | |||
| Dividend Yield | 7.42% | |||
| Div. Per Share (Most Recent) | $0.31 | |||
| Dividend Per Share (TTM) | $1.24 | |||
| Payout Ratio (TTM) | -69.96% | |||
| Dividend Per Share (Most Recent) | $0.31 | |||
| Company Info | HR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 615 269 8175 | |||
| Address | 3310 West End Avenue Nashville, TN 37203 | |||
| Website | www.healthcarerealty.com | |||
| Country | United States | |||
| Year Founded | 1992 | |||
| Profitability | HR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 2.62% | |||
| Profit Margin | -51.60% | |||
| Management Effectiveness | HR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 0.18% | |||
| Return on Equity | -- | |||
| Income Statement | HR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.23B | |||
| Total Revenue (TTM) | 1.27B | |||
| Revenue Per Share | $3.61 | |||
| Gross Profit (TTM) | 791.62M | |||
| EBITDA (TTM) | 755.66M | |||
| EBIT (TTM) | 33.34M | |||
| Net Income (TTM) | -654.49M | |||
| Net Income Avl. to Common (TTM) | -654.49M | |||
| Total Revenue Growth (Q YOY) | -6.07% | |||
| Earnings Growth (Q YOY) | -159.66% | |||
| EPS Diluted (TTM) | -1.79 | |||
| EPS Diluted Growth (Q YOY) | -183.08% | |||
| Balance Sheet | HR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 68.92M | |||
| Cash Per Share (Q) | $0.20 | |||
| Total Current Assets (Q) | 532.93M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 5.31B | |||
| Current Ratio (Q) | 0.553 | |||
| Book Value Per Share (Q) | $14.93 | |||
| Total Assets (Q) | 10.65B | |||
| Total Current Liabilities (Q) | 963.63M | |||
| Total Debt (Q) | 4.96B | |||
| Total Liabilities (Q) | 5.35B | |||
| Total Common Equity (Q) | 5.23B | |||
| Cash Flow | HR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 900.92M | |||
| Cash from Financing (TTM) | -1.36B | |||
| Net Change in Cash (TTM) | 43.22M | |||
| Levered Free Cash Flow (TTM) | 405.20M | |||
| Cash from Operations (TTM) | 501.62M | |||
